Skip to main content
. 2012 Apr 15;103(6):1065–1070. doi: 10.1111/j.1349-7006.2012.02249.x

Figure 2.

Figure 2

Correlation between log% change in circulating endothelial progenitor cells (CEPs) and the percent tumor shrinkage according to RECIST after two cycles of chemotherapy (A) or the best percent tumor shrinkage during chemotherapy (B) in patients with non‐small‐cell lung cancer (n = 38). Pearson R = 0.005 and 0.004, respectively.